Clinical trials
Phase 1 trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 14 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 13 |
| 2019 | 6 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 109 |
| Terminated | 18 |
| Unknown status | 10 |
| Recruiting | 8 |
| Active, not recruiting | 8 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Orion Corporation, Orion Pharma | 35 |
| Bayer | 11 |
| H. Lundbeck A/S | 6 |
| Turku University Hospital | 6 |
| Helsinki University Central Hospital | 5 |
| Novartis Pharmaceuticals | 5 |
| University of Turku | 5 |
| GlaxoSmithKline | 4 |
| Hoffmann-La Roche | 4 |
| Herantis Pharma Plc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 10 |
| Neoplasms | 10 |
| Alzheimer Disease | 8 |
| Parkinson Disease | 6 |
| Leukemia, Myeloid, Acute | 4 |
| Central Nervous System Diseases | 3 |
| Lymphoma | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Melanoma | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 51 to 75 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.